Robert M Mader (Robert Mader)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

Journal of personalized medicine

Cancers

Biomolecular concepts

Scientific reports

Medical University of Vienna

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Vienna Jan 01 1986

Austria

Programme Director "Molecular Pharmacology" :: Department of Medicine I

Publications

Thomas Bartl, Christoph Grimm, Robert M Mader, Christoph C Zielinski, Gerald Prager, Matthias Unseld, Merima Herac-Kornauth
Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer. Journal of personalized medicine 13 (8) (2023)
Paul Strasser, Bianca Montsch, Silvia Weiss, Haider Sami, Christoph Kugler, Sonja Hager, Hemma Schueffl, Robert M Mader, Oliver Brüggemann, Christian R Kowol, Manfred Ogris, Petra Heffeter, Ian Teasdale
Degradable Bottlebrush Polypeptides and the Impact of their Architecture on Cell Uptake, Pharmacokinetics, and Biodistribution In Vivo. Small (Weinheim an der Bergstrasse, Germany) (2023)
Hossein Taghizadeh, Agnieszka Maj-Hes, Gerald W Prager, Leonhard Müllauer, Robert M Mader
Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors. Cancers 14 (8) (2022)
Hemma Schueffl, Sarah Theiner, Gerrit Hermann, Josef Mayr, Philipp Fronik, Diana Groza, Sushilla van Schonhooven, Luis Galvez, Nadine S Sommerfeld, Arno Schintlmeister, Siegfried Reipert, Michael Wagner, Robert M Mader, Gunda Koellensperger, Bernhard K Keppler, Walter Berger, Christian R Kowol, Anton A Legin, Petra Heffeter
Albumin-targeting of an oxaliplatin-releasing platinum(iv) prodrug results in pronounced anticancer activity due to endocytotic drug uptake in vivo. Chemical science 12 (38) (2021)
Jakob Nedomansky, Werner Haslik, Ursula Pluschnig, Christoph Kornauth, Christine Deutschmann, Stefan Hacker, Günther G Steger, Rupert Bartsch, Robert M Mader
Tissue distribution of epirubicin after severe extravasation in humans. Cancer chemotherapy and pharmacology 88 (2) (2021)
Hossein Taghizadeh, Robert M Mader, Leonhard Müllauer, Thorsten Fuereder, Alexandra Kautzky-Willer, Gerald W Prager
Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers. Cancers 12 (11) (2020)
Hossein Taghizadeh, Robert M Mader, Leonhard Müllauer, Friedrich Erhart, Alexandra Kautzky-Willer, Gerald W Prager
Precision Medicine for the Management of Therapy Refractory Colorectal Cancer. Journal of personalized medicine 10 (4) (2020)
Daniel Senfter, Mahzeiar Samadaei, Robert M Mader, Johannes Gojo, Andreas Peyrl, Georg Krupitza, Marcel Kool, Martin Sill, Christine Haberler, Gerda Ricken, Thomas Czech, Irene Slavc, Sibylle Madlener
High impact of miRNA-4521 on FOXM1 expression in medulloblastoma. Cell death & disease 10 (10) (2019)
Christian Schoergenhofer, Michael Schwameis, Christa Firbas, Johann Bartko, Ulla Derhaschnig, Robert M Mader, Raute Sunder Plaßmann, Petra Jilma-Stohlawetz, Kalpna Desai, Priya Misra, Ulrich Jäger, Bernd Jilma
Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing. Scientific reports 8 (1) (2018)
Daniel Senfter, Sibylle Madlener, Georg Krupitza, Robert M Mader
The microRNA-200 family: still much to discover. Biomolecular concepts 7 (5-6) (2017)

Robert M Mader.css-eqlu8i{font-size:small;padding-left:4px;} (Robert Mader)

Publication Activity (10 Years)

Top Topics

Top Venues

Robert M Mader (Robert Mader)